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Background. Human malaria susceptibility is determined by multiple genetic factors. It is unclear, however, which genetic vari-
ants remain important over time.
Methods. Genetic associations of 175 high-quality polymorphisms within several malaria candidate genes were examined in a 
sample of 8096 individuals from northeast Tanzania using altitude, seroconversion rates, and parasite rates as proxies of historical, 
recent, and current malaria transmission intensity. A principal component analysis was used to derive 2 alternative measures of 
overall malaria propensity of a location across different time scales.
Results. Common red blood cell polymorphisms (ie, hemoglobin S, glucose-6-phosphate dehydrogenase, and α-thalassemia) 
were the only ones to be associated with all 3 measures of transmission intensity and the first principal component. Moderate asso-
ciations were found between some immune response genes (ie, IL3 and IL13) and parasite rates, but these could not be reproduced 
using the alternative measures of malaria propensity.
Conclusions. We have demonstrated the potential of using altitude and seroconversion rate as measures of malaria transmis-
sion capturing medium- to long-term time scales to detect genetic associations that are likely to persist over time. These measures 
also have the advantage of minimizing the deleterious effects of random factors affecting parasite rates on the respective association 
signals.
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Malaria caused by the parasite Plasmodium falciparum con-
tinues to have a significant impact on public health in tropical 
areas of the world. Although major advances have been made 
in malaria control, there is increasing parasite drug resistance 
and mosquito insecticide resistance, and no fully efficacious 
vaccine exists. A better understanding of the factors associated 
with immunity to and protection from malaria may contribute 
to the development of vaccines and other therapies. It is widely 
recognized that malaria has exerted strong genetic selection on 
the human genome [1]. Mutations leading to sickle cell trait 
(hemoglobin S [HbS]) were central to the hypothesis, pro-
posed by Haldane in the 1940s [2], that the high prevalence of 
hemoglobinopathies in southern European and African popu-
lations was due to the protection against malaria in carriers of 
these traits. 
This hypothesis has subsequently been validated for several 
hemoglobinopathies, indirectly by the concordance between the 
prevalence of malaria parasites and frequencies of mutated alleles 
[3, 4] and directly through protection from disease in carriers 
[4–7]. The different geographic distributions of HbS, α-thalas-
semia, glucose-6-phosphate dehydrogenase (G6PD) deficiency, 
ovalocytosis, and the Duffy-negative blood group are examples 
of the general principle that different genetic variants have arisen 
and been selected in different populations (see [8] for a review). 
The most striking example is the β-globin HBB gene, in which 3 
different coding single-nucleotide polymorphisms (SNPs) con-
fer protection against malaria: Glu6Val (HbS), Glu6Lys (hemo-
globin C), and Glu26Lys (hemoglobin E). The mechanisms by 
which the various hemoglobinopathies protect individuals from 
malaria are not fully understood [9, 10].
There is increasing evidence that other traits, particularly 
those relevant to immunity and inflammation, may also be 
selected by malaria infection; these include polymorphisms 
in genes encoding tumor necrosis factor (TNF, MHC class III 
region, reviewed in [11]; Toll-like receptors (TLR4, TLR9) [12]; 
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CD40 ligand (CD40L) [13]; interferon γ (IFNG), reviewed in 
[14]; and nitric oxide synthase type 2 (NOS2A), reviewed in 
[15]). These associations are consistent with the observation 
that disease severity (and thus malaria-related mortality risk) 
is associated with the strength of the inflammatory response to 
malaria infection [16].
The bulk of the evidence linking genotype to malaria sus-
ceptibility stems from studies of severe and/or complicated 
disease ,where the genetic association might be the strongest 
owing to the close temporal relationship between genotype, 
consequence (infection or inflammation), and effect (disease or 
death). Conversely, genetic traits that reduce the risk of becom-
ing patently infected with malaria [17], such as those operat-
ing at the pre-erythrocytic stage of infection, are less likely to 
be detected because their effect is too small or because con-
trols tend to be drawn from those with patent but nonsevere 
infection. However, these traits may become apparent in large 
population-based studies. Landmark studies by Flint et al [4, 5] 
in Melanesia were the first to use the natural cline in malaria, 
associated with latitude and altitude, to demonstrate a positive 
correlation between malaria transmission and the prevalence of 
α-thalassemia, an observation replicated in northeast Tanzania, 
where a negative correlation was observed between altitude (as 
a proxy for malaria transmission) and the prevalence of HbS 
and α-thalassemia heterozygotes [3]. Integrated approaches 
have now shown that the frequency of different genetic poly-
morphisms varies with malaria transmission intensity at a 
regional and at a global scale [18–20].
Malaria transmission intensity can be defined in a variety of 
ways, including the incidence of clinical disease, the frequency 
of being bitten by infected mosquitoes, and the environmental 
suitability for transmission [21]. These definitions are linked to 
different epidemiological measures that capture distinct aspects 
of transmission, including risk of exposure (geographic, cli-
matic, and mosquito-related variables), actual exposure (sero-
logical data), infection (parasitological variables) and disease 
(clinical data). These measures are associated with differing 
time scales, ranging from generations (for risk) to years (for 
exposure), months or weeks (for infection) or days (for disease). 
In turn, these different measures may be associated with differ-
ent genetic markers, depending on the clinical or parasitologi-
cal consequences of the respective genetic effects. In the current 
study, we combine a candidate-gene approach with different 
measures of malaria transmission to investigate malaria genetic 
associations in populations living in northeast Tanzania.
METHODS
Ethical Approvals
Ethical approval was obtained from the London School of 
Hygiene and Tropical Medicine, Kilimanjaro Christian Medical 
College in Tanzania, and the Tanzanian National Medical 
Research Institute.
Study Sites
The study was conducted in the Kilimanjaro and Tanga regions 
of northeast Tanzania. Cross-sectional age-stratified malario-
metric surveys, conducted in 24 villages in 6 transects (Figure 1 
and Table 1) after the short rainy season in November 2001 and 
again after the long rains the following June (2002), as described 
elsewhere [22], generated between 194 and 435 samples from 
unique individuals 1–45  years old in each village. To control 
for population structure, each transect was selected to approxi-
mately represent a specific ethnic group (Table 1).
A finger-prick blood sample was collected from each par-
ticipant for assessment of parasitemia, antimalarial antibody 
responses and genotype. Written consent was provided by all 
participants or by their guardians, and clinical illnesses were 
treated in accordance with national guidelines.
Blood Slide Examination
The presence of P.  falciparum parasites was determined by 
microscopic examination of Giemsa-stained blood smears. 
Asexual (blood-stage) parasite density was calculated relative to 
200 white blood cells [22]. Each slide was read by 2 independent 
microscopists, and noncongruent readings were resolved by a 
third reader.
Enzyme-Linked Immunosorbent Assays and Seroconversion Rate 
Calculation
Serological characterization of the samples through enzyme-
linked immunosorbent assays and calculation of seroconversion 
rate (SCR) (ie, the rate at which individuals become seroposi-
tive per year) has been published elsewhere [23]. Briefly, indi-
rect enzyme-linked immunosorbent assays were used to detect 
immunoglobulin G (antibodies to blood-stage malaria antigens 
merozoite surface protein 119 [K1-Wellcome genotype] and 
apical membrane antigen 1 [3D7], produced as described else-
where [24, 25]). Antibody responses in serum from Europeans 
with no previous exposure to malaria were used to define a cut-
off for seropositivity (mean optical density plus 3 standard devi-
ations) for each antigen. Seroprevalence was calculated for each 
village as the respective proportion of seropositive individuals. 
SCRs were estimated for each antigen and village using revers-
ible catalytic models, where each individual transits between 
seronegativity and seropositivity over time under the assump-
tion of stable and constant malaria transmission intensity.
DNA Extraction and Genotyping
DNA was extracted from the archived, pelleted, blood samples 
using Nucleon kits (Hologic) according to the manufacturer’s 
instructions. SNP genotypes were determined by means of prim-
er-extension mass spectrometry using the Sequenom iPlex plat-
form MassARRAY system (Agena Bioscience) at the Wellcome 
Trust Centre for Human Genetics in Oxford. The α3.7-thalassemia 
deletion was identified using polymerase chain reaction amplifi-
cation, as described elsewhere [3]. A total of 275 SNP assays were 
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designed incorporating a core set of 65 SNPs (as described else-
where [26]), plus a further 137 autosomal SNPs selected in genes 
associated with or described as associated with antibody produc-
tion [27], and another 73 identified in a previous study [28].
Statistical Analysis
SNPs were removed from the analysis if monomorphic, if the allele 
frequency was <1%, if >10% of their genotypes were missing, or 
if there was evidence of extreme deviation from Hardy-Weinberg 
equilibrium (P value < .001; χ2 test). Because the sample and actual 
population sizes are close in many villages (mostly those in the 
highlands owing to their geographic isolation), genetic associ-
ation analyses were conducted using aggregated data from each 
village: mean altitude, parasite prevalence, SCR, genotype distri-
butions, male-female ratio, and transect of residence. Genotype 
frequencies of each SNP were summarized for each village and 
then rescaled using the log-additive transformation [29], with the 
heterozygous genotype frequencies used as reference, that is,
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Missing genotype frequencies of the α-thalassemia locus 
from 11 villages [30] plus missing SCRs from 3 other villages 
(Table  1) were jointly imputed via multiple imputation using 
chained equations [31]. Multiple imputation was performed 
at the village level and not at the individual level as described 
elsewhere [30]. Altitude, log odds of parasite rate, sex log ratio, 
and transect of residence were included in the imputation mod-
els as fixed covariates. Postimputation estimates and standard 
errors were based on 100 imputed data sets and determined as 
described elsewhere [32].
Evidence for genetic association of a given SNP with each 
malaria transmission measure was assessed by multivariate lin-
ear regression based on a multivariate normal distribution, using 
the log-additive genotype distributions as dependent variables 
and the logarithm of the male-female ratio and the transect of 
residence and the different malaria transmission measures as 
covariates. Models were tested with SCR and altitude in linear or 
in log, choosing the scale that provided the best fit for the data. 
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Figure 1. Map of study sites and the corresponding transects: Rombo (transect 1), North Pare (transect 2), South Pare (transect 3), West Usambara 1 (transect 4), West 
Usambara 2 (transect 5), and West Usambara 3 (transect 6). Locations of 8 meteorological stations are also shown (asterisks).
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Log odds of parasite prevalence were used in the analysis. The 
Wilks likelihood ratio was then used to compare models with or 
without a given malaria transmission measure. For consistency, 
–log10(P value) was considered a measure of statistical signif-
icance. High values of this measure provided evidence for an 
association between a given genetic marker and the respective 
transmission intensity measure. Because data refer to a set of 
candidate genes for which there is a priori evidence of associa-
tion with malaria susceptibility, a significance level of 1% (eg, 2 
for –log10[P value]) was used in each individual association test. 
Finally, the fitted regression models were statistically checked by 
residual analyses (eg, normality checks or trends in the residuals).
A principal component analysis of altitude, SCR, and parasite 
rate enabled the derivation of alternative “latent” measures of 
malaria transmission. Genetic association was assessed again, 
as described above. Association analyses involving X chromo-
some SNPs were performed on male and female data separately. 
The underlying false discovery rates were finally estimated for 
the different analyses (Supplementary Table S1). These rates 
ranged from 0.08 to 0.19; thus, one could not rule out that some 
of the detected association signals, namely, those close to the 
significance threshold, were due to chance. All analyses were 
carried out with R software, using 2 packages: MICE (for data 
imputation) and Genetics (for genetic analysis) (see https://
cran.r-project.org/).
RESULTS
A total of 8241 samples were genotyped for an initial set of 
275 SNPs by Sequenom technology. After implementation of 
quality control protocols, data from 8096 individuals across 
Table 1. Baseline Information on Different Malaria Transmission Measures for the 24 Villages Considered in the Study
Transect and Village Name (sample 
size)a Altitude, Mean (Range), m
Serology Parasite Rate, %
Seroprevalence, % SCRb Overall Age 2–10 y 
Kilimanjaro region
 Rombo (Wachaga, 80%)
  Mokala (413) 1702 (1623–1788) 20.7 0.027 4.4 5.6
  Machame Aleni (249) 1421 (1380–1482) 26.2 0.038 1.3 0.9
  Ikuini (363) 1160 (1118–1215) 24.2 0.033 12.3 11.0
  Kileo (247) 723 (721–724) 78.6 0.343 6.6 8.6
 North Pare (Wapare, 92%)
  Kilomeni (351) 1556 (1384–1745) 36.1 0.044 3.4 1.0
  Lambo (295) 1187 (1146–1231) 62.7 0.147 2.5 3.9
  Ngulu (405) 831 (798–863) 93.4 0.765 6.2 8.5
  Kambi ya Simba (281) 745 (716–767) 90.9 0.626 10.1 13.8
 South Pare (Wapare, 90%)
  Bwambo (422) 1598 (1564–1643) 25.5 0.033 3.5 3.4
  Mpinji (386) 1445 (1307–1667) 35.3 0.054 2.8 3.2
  Goha (408) 1162 (1079–1228) 59.8 0.144 11.4 14.2
  Kadando (414) 528 (525–531) 79.7 0.333 23.4 28.3
Tanga region
 West, Usambara 1 (Wasambaa, 88%)
  Emmao (199) 1845 (1810–1872) 17.3 0.019 3.7 0.0
  Handei (417) 1425 (1372–1517) 68.1 0.209 27.9 32.1
  Tewe (372) 1049 (965–1126) 69.9 0.205 34.4 35.2
  Mng’alo (398) 416 (406–455) 90.9 0.802 49.2 69.3
 West, Usamabara 2 (Wasambaa, 88%)
  Kwadoe (435) 1523 (1473–1603) 41.6 0.073 8.5 6.5
  Funta (315) 1279 (1236–1322) 73.7 0.268 24.7 27.6
  Tamota (417) 1176 (1073–1338) 59.3 0.140 24.7 24.8
  Mgila (391) 432 (406–455) 86.5 0.543 41.4 55.6
 West, Usambara 3 (Wasambaa, 65%)
  Magamba (237) 1685 (1659–1751) 39.4c 0.048c 3.2 1.0
  Ubiri (194) 1216 (1174–1262) 47.0c 0.052c 16.2 14.8
  Kwemasimba (247) 662 (636–691) 64.7c 0.103c 25.3 32.4
  Mgome (240) 196 (165–208) 96.5 0.941 40.2 69.0
Abbreviation: SCR, seroconversion rate.
aThe major ethnic group and its respective percentage is given parenthetically after each transect name.
bSCR was defined as the yearly average frequency at which seronegative individuals became seropositive.
cEstimates based on data imputation performed using MICE software.
Downloaded from https://academic.oup.com/jid/article-abstract/216/1/45/3852509
by London School of Hygiene & Tropical Medicine user
on 18 January 2018
Genetic Association and Malaria Transmission • JID 2017:216 (1 July) • 49
175 high-quality SNPs were available for the final analysis. 
For α3.7-thalassemia, 2997 samples were successfully geno-
typed from 13 villages (Mgome in Tanga and 4 villages each 
from Kilimanjaro, South Pare, and West Usambara 2), and data 
imputation was performed in the remaining 11 villages.
Association of Sickle Cell and α-Thalassemia Traits and Point Mutations 
in CD36 and G6PD With Historical, Recent, and Current Measures of 
Malaria Transmission
Genetic variation analysis confirmed previous observations of 
significant inverse gradients of α-thalassemia and HbS and alti-
tude (−log10[P value], 5.30 and 4.33, respectively; Table 2 and 
Supplementary Figure S1A) [3]. The odds of noncarrier versus 
HbS carrier increased by approximately 0.16 per 100 m increase 
in altitude, whereas the same odds of the noncarriers of the 
α-thalassemia trait increased by approximately 0.08 per 100 m 
using data imputation. Similar genetic effects for the α-thalas-
semia trait were obtained for the complete data of 13 villages 
but with increased standard errors. Strong associations were 
found between genotype frequency of these 2 traits and SCR 
and parasite prevalence (−log10[P value], >2.61; Table 2 and 
Supplementary Figure S1B and S1C).
Significant associations were detected between all malaria 
transmission measures and SNP rs3211938 in CD36 (−log10[P 
value], >2.58; Table 2 and Supplementary Figure S1) and sev-
eral point mutations within the X-linked G6PD locus (Table 3 
and Supplementary Figure S2). For G6PD, the associations were 
most pronounced among female participants and for current 
transmission intensity (parasite prevalence) compared with his-
torical or recent measures of malaria transmission. These asso-
ciations are in agreement with recent findings from the same 
area, showing that heterozygous women are more protected 
against severe malaria than men [33].
Association Between Variation Within Immune Response Genes and 
Current Malaria Transmission Levels
Variation in frequency of a number of SNPs located within 
immune response associated genes is statistically associated 
Table  2. Significant Genetic Associations Between Malaria Transmission Measures and Autosomal SNPs Using −log10(P value) as an Association 
Measure With a Cutoff of 2a
Measure and SNP Chr Position Gene Alleles A/B Scale −log10(P Value)
Estimates (SE)
log fAA/fAB log fBB/fAB
Altitude
 rs11575518 7 50535681 DDC G/A Log 2.00 0.821 (0.551)b −0.166 (0.087)b
 rs3211938 7 80300449 CD36 T/G Log 3.73 0.575 (0.153)b,c NA
 rs334 11 5248232 HBB A/T Linear 4.33 0.162 (0.032)b,c NA
 α-Thalassemiad 16 222500 HBA2 α+/α− Linear 3.28 0.078 (0.015)b −0.105 (0.153)b
 α-Thalassemiae 16 222500 HBA2 α+/α− Linear 5.30 0.081 (0.019)b −0.071 (0.027)b
SCR
 rs3211938 7 80300449 CD36 T/G Log 2.59 −0.241 (0.084)c NA
 rs334 11 5248232 HBB A/T Log 3.48 −0.591 (0.151)c NA
 α-Thalassemiad 16 222500 HBA2 α+/α− Log 5.58 −0.337 (0.086) 0.443 (0.709)
 α-Thalassemiae 16 222500 HBA2 α+/α− Linear 5.30 −0.315 (0.081) 0.294 (0.113)
Parasite rate
 rs31481 5 131397202 IL3 G/A Log odds 2.14 −0.097 (0.032) −0.091 (0.116)
 rs3900945 5 131592870 PDLIM4 C/T Log odds 2.49 −0.073 (0.047) 0.003 (0.091)
 rs10463891 5 131597392 PDLIM4 G/A Log odds 2.65 −0.080 (0.046) −0.031 (0.082)
 rs2069744 5 131994669 IL13 C/T Log odds 2.20 −0.025 (0.043) 0.017 (0.052)
 rs2242665 6 31839309 CTLA4 G/A Log odds 2.04 −0.080 (0.072) 0.038 (0.049)
 rs11983581 7 50532888 DDC A/T Log odds 2.54 0.470 (0.309) 0.079 (0.053)
 rs11982772 7 50533062 DDC A/C Log odds 2.84 0.077 (0.047) 0.467 (0.310)
 rs11575527 7 50534327 DDC G/C Log odds 2.59 0.084 (0.053) 0.485 (0.308)
 rs11575522 7 50535395 DDC C/T Log odds 2.63 0.076 (0.051) 0.476 (0.305)
 rs11575518 7 50535681 DDC G/A Log odds 2.83 0.483 (0.308) 0.083 (0.050)
 rs3211938 7 80300449 CD36 T/G Log odds 3.19 −0.235 (0.102)c NA
 rs334 11 5248232 HBB A/T Log odds 2.61 −0.610 (0.181)c NA
 α-Thalassemiad 16 222500 HBA2 Α+/α− Log odds 3.39 −0.390 (0.081) 1.098 (0.678)
 α-Thalassemiae 16 222500 HBA2 Α+/α− Log odds 5.78 −0.377 (0.086) 0.288 (0.133)
Abbreviations: Chr, chromosome; NA, not applicable; SCR, seroconversion rate; SE, standard error; SNP, single-nucleotide polymorphism.
aSNPs were deemed significant if −log10(P value) was >2. 
bEstimates per 100-m increase in altitude. 
cEstimates based on log fAA/(fAB+ fBB).
dResults based on complete data (13 villages). 
eResults based on data imputation performed using MICE software.
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with parasite rate (Table  2). These SNPs included 5 within 
DDC (which encodes dopa decarboxylase/aromatic L-amino 
acid decarboxylase, an essential component of the dopa-
mine/serotonin/tryptamine pathway); SNPs in genes encod-
ing interleukin 3, interleukin 13, and CTLA-4; and 2 SNPs 
in PDLIM4 (believed to play a role in bone development and 
homeostasis). Note, however, that the signals of association 
are moderate compared with those for sickle cell, α-thalas-
semia, and G6PD.
Association of Alternative Measures of Malaria Propensity With Genetic 
Variation
Although altitude, SCR and parasite prevalence capture dif-
ferent time scales of malaria transmission, these measures 
were highly correlated with each other (Supplementary Table 
S2). Altitude was inversely correlated with both SCR and par-
asite rate (R2 < −0.688) whereas SCR was positively correlated 
with parasite rate (R2 = 0.568). These correlations were further 
explored using 2 principal components that accounted for 
95% of the total variation of these measures (Supplementary 
Table S2). These principal components could be interpreted 
as 2 independent measures of malaria propensity of a village 
across historical, recent, and current infection. The respective 
derived data were then tested for genetic association (Figure 
2 and Table 4). HbS, α-thalassemia, CD36, several SNPs in 
the G6PD locus either in female or male participants, and 
borderline associations with genetic markers at the DDC 
and PDLIM4 loci were associated with the first principal 
component. For the second principal component, there was 
an enrichment of immune response genes (IL3, TNF, TLR4, 
Table 3. Significant Genetic Associations Between Malaria Transmission Measures and X-linked G6PD SNPs Using −Log10(P value) as an Association 
Measure With a Cutoff of 2a
Measure and SNP Position Alleles A/B Scale −log10(P Value)
Estimates (SE)
log fAA/fAB log fBB/fAB log fA/fB
Altitude, female participants
 rs28470352 153753490 T/A Linear 3.18 0.023 (0.006) −0.008 (0.031) NA
 rs5986990 153761628 G/A Linear 3.36 0.022 (0.006) −0.007 (0.031) NA
 rs2515905 153762075 G/A Log 2.51 0.214 (0.075) 0.379 (0.647) NA
 rs2515904 153762771 G/C Log 2.76 0.204 (0.059) 0.245 (0.651) NA
 rs1050829 153763492 T/C Linear 2.16 0.018 (0.007) −0.009 (0.033) NA
 rs762516 153764663 C/T Log 2.61 0.201 (0.061) 0.251 (0.638) NA
Altitude, male participants
 rs1050829 153763492 T/C Linear 2.05 NA NA 0.027 (0.010)
SCR, female participantsb
 rs28470352 153753490 T/A Log 2.33 −0.069 (0.030) −0.064 (0.128) NA
 rs5986990 153761628 G/A Log 2.53 −0.062 (0.029) −0.095 (0.127) NA
 rs2515905 153762075 G/A Linear 2.12 −0.345 (0.176) −0.939 (1.372) NA
 rs2515904 153762771 G/C Linear 3.22 −0.430 (0.128) −0.685 (1.380) NA
 rs1050828 153764217 C/T Linear 2.85 −0.591 (0.195) −0.603 (1.136) NA
 rs762516 153764663 C/T Linear 3.00 −0.422 (0.133) −0.612 (1.354) NA
SCR, male participantsb
 rs1050828 153764217 C/T Log 3.24 NA NA −0.114 (0.050)
Parasite rate, female participants
 rs28470352 153753490 T/A Log odds 5.04 −0.109 (0.029) 0.211 (0.135) NA
 rs2230037 153760654 G/A Log odds 2.43 0.170 (0.052) 0.019 (0.061) NA
 rs5986990 153761628 G/A Log odds 5.17 −0.104 (0.027) 0.154 (0.139) NA
 rs2515905 153762075 G/A Log odds 2.57 −0.107 (0.044) 0.231 (0.363) NA
 rs2515904 153762771 G/C Log odds 4.14 −0.113 (0.034) 0.288 (0.360) NA
 rs1050829 153763492 T/C Log odds 4.66 −0.097 (0.030) 0.221 (0.141) NA
 rs1050828 153764217 C/T Log odds 3.88 −0.070 (0.062) 0.379 (0.288) NA
 rs762516 153764663 C/T Log odds 3.84 −0.112 (0.035) 0.289 (0.353) NA
Parasite rate, male participants
 rs28470352 153753490 T/A Log odds 2.96 NA NA 0.148 (0.051)
 rs1050829 153763492 T/C Log odds 4.56 NA NA 0.143 (0.036)
 rs1050828 153764217 C/T Log odds 4.35 NA NA 0.125 (0.059)
 rs762516 153764663 C/T Log odds 3.12 NA NA 0.164 (0.060)
Abbreviations: NA, not applicable; SCR, seroconversion rate; SE, standard error; SNP, single-nucleotide polymorphism.
aSNPs were deemed significant if −log10(P value) was >2. 
bResults based on data imputation performed using MICE software.
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and CR1), although the corresponding associations were not 
strong (2.00 < −log10(P value) < 3.00). Of note, the genetic 
variation at the G6PD locus could be explained by both prin-
cipal components.
DISCUSSION
Geographic variation in the frequency of hemoglobinopa-
thies provided the first evidence that these traits might protect 
against disease or death caused by malaria. They tend to be rare 
in areas of low malaria transmission and more common in areas 
of higher transmission. In this study, we have used local alti-
tude-dependent variations in malaria transmission intensity to 
both confirm and identify additional human genetic polymor-
phisms relevant for individuals living in the study area.
The present study focused on a set of genetic polymorphisms 
previously implicated in resistance to malaria. Replication of 
many of these associations has been difficult because, although 
some polymorphisms are likely to be genuinely (and causally) 
associated with malaria resistance, other associations may have 
arisen by chance (eg, in small studies or owing to population 
structure or instability of malaria infection measures) or may 
be closely linked to causal variants in some populations but not 
in others [34]. Possible population structure was controlled by 
a study design comprising transects that represented specific 
ethnic groups. Well-matched age distributions and sample sizes 
ensured similar precision of the aggregated data across villages. 
The use of altitude and SCR in the genetic analysis reduced 
the chance of detecting sporadic associations due to the intrin-
sic instability of the parasite rate in estimating the underlying 
malaria transmission intensity. Altitude, through the effect of 
temperature on sporogonic development of malaria parasites in 
the mosquito, is a stable proxy for historical, recent, and ongo-
ing malaria exposure stretching back to the original settlement 
of these villages some 4000–5000 years ago [35]. 
SCR is a more direct measure of exposure to infection but 
estimated from a mathematical model that assumed constant 
and stable malaria transmission intensity over time. Such a 
model, although fitting the data well, might mask possible slow 
(linear) trends in disease transmission intensity occurring over 
time [36]. Estimates of SCR should be then seen as averages 
of recent transmission intensities. This averaging effect might 
reduce the power of identifying genetic associations with more 
8
A
B
Female participants Females participantsMales participants Males participants
6
4
rs10463891
rs3900945
PDLIM4
rs11575518
rs28470352
rs1050828
rs5986990
rs1050829
rs2515904
rs762516
rs2515905 rs28470352
rs1050828
rs28470352
rs1050829
rs2515904
rs5986990
rs1050828
rs762516
rs1050829
rs3211938
rs334
rs17047660
rs35415145
rs272893
rs2069744
rs3093662
rs4986790
TLR4
rs3093662
TNF
rs4526098
RAD50
IL13
SLC22A4
IL3
CR1
α-Thalassemia
HBA2
HBB
CD36
rs11982772
DDC–l
og
10
(P
va
lu
e)
2
0
8
6
4
–l
og
10
(P
va
lu
e)
2
0
8
6
4
–l
og
10
(P
va
lu
e)
2
0
8
6
4
–l
og
10
(P
va
lu
e)
2
0
Figure 2. Association between single-nucleotide polymorphisms (SNPs) and 2 principal components generated from summary data of the 3 malaria transmission measures 
for each village. A, Association of autosomal SNPs and each principal component. B, Association of X-linked SNPs and each principal component. Dashed lines represent the 
cutoff set for significant association. Specifically, a given genetic association was deemed significant for SNPs when the −log10(P value) was >2 (ie, P < .01).
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subtle effects. Notwithstanding this limitation, SCR analy-
sis suggests that malaria transmission intensities in the study 
villages could be considered approximately stable for about 
40 years before sampling in 2001 [23], and probably before this 
[37]. The same likely holds true for the resulting genetic associa-
tion due to malaria, given that there have been no major migra-
tions or admixture events in the recorded history of this area
The approach presented here was validated by strong genetic 
associations of HbS, α-thalassemia, and G6PD deficiency, each 
of which showed marked variation with the different malaria 
transmission intensities. As anticipated, geographic variation 
in the frequency of sickle cell trait and α-thalassemia was most 
highly correlated with altitude and is thus a stable marker of 
malaria exposure over many generations. Moreover, both 
these traits were also highly associated with SCR and parasite 
prevalence, suggesting stable genetic associations over time. 
Interestingly, G6PD deficiency was most significantly associ-
ated with parasite rate (stronger in female than in male partic-
ipants) rather than with altitude or SCR. This may reflect the 
fact that mutations in this gene protect from severe clinical out-
comes rather than infection per se [2].
Given the geographic variation in the prevalence of classic 
malaria resistance traits and their strong association with trans-
mission intensity, it was surprising that relatively few of the other 
Table 4. Detected Associations Between the SNPs and the First 2 PCs Using A Statistically Significant Cutoff of 2 for −log10(P value)
Measure, SNP Chr Position Gene Alleles A/B −log10(P Value)
Estimates (SE)
log fAA/fAB log fBB/fAB log fA/fB
1st PC, overall
 rs3900945 5 131592870 PDLIM4 C/T 2.25 −0.063 (0.030) 0.040 (0.065) NA
 rs10463891 5 131597392 PDLIM4 G/A 2.03 −0.061 (0.030) 0.019 (0.055) NA
 rs11982772 7 50533062 DDC G/A 2.03 −0.049 (0.032) 0.317 (0.207) NA
 rs11575518 7 50535681 DDC G/A 2.18 0.326 (0.206) 0.054 (0.034) NA
 rs3211938 7 80300449 CD36 T/G 3.30 −0.189 (0.063)a NA NA
 rs334 11 5248232 HBB A/T 4.12 −0.485 (0.102)a NA NA
 α-Thalassemia 16 222500 HBA2 α+/α− 7.12 −0.262 (0.056) 0.226 (0.085) NA
1st PC, female 
participants
 rs28470352 X 153753490 G6PD T/A 3.88 −0.069 (0.020) 0.034 (0.097) NA
 rs5986990 X 153761628 G6PD G/A 4.12 −0.064 (0.019) 0.012 (0.097) NA
 rs2515905 X 153762075 G6PD G/A 2.39 −0.067 (0.030) −0.128 (0.244) NA
 rs2515904 X 153762771 G6PD G/C 3.53 −0.074 (0.023) −0.089 (0.245) NA
 rs1050829 X 153763492 G6PD T/C 3.01 −0.056 (0.022) 0.037 (0.101) NA
 rs1050828 X 153764217 G6PD C/T 2.61 −0.063 (0.040) 0.012 (0.203) NA
 rs762516 X 153764663 G6PD C/T 3.29 −0.072 (0.024) −0.086 (0.240) NA
1st PC, male participants
 rs28470352 X 153753490 G6PD T/A 2.30 NA NA −0.0812 (0.0370)
 rs1050829 X 153763492 G6PD T/C 3.08 NA NA −0.0766 (0.0283)
 rs1050828 X 153764217 G6PD C/T 3.50 NA NA −0.0838 (0.0392)
2nd PC, overall
 rs17047660 1 207782856 CR1 A/G 2.04 0.135 (0.095) 0.027 (0.219) NA
 rs35415145 5 131396406 IL3 C/T 2.24 0.070 (0.229)a NA NA
 rs272893 5 131663062 SLC22A4 A/G 2.75 −0.214 (0.235) −0.098 (0.073) NA
 rs4526098 5 131892979 RAD50 G/A 2.03 −0.225 (0.133) 0.026 (0.121) NA
 rs2069744 5 131994669 IL13 C/T 2.18 −0.085 (0.111) −0.133 (0.127) NA
 rs361525 6 31543101 TNF G/A 2.86 0.258 (0.155) −0.482 (0.903) NA
 rs3093662 6 31544189 TNF A/G 2.95 0.138 (0.128) −0.672 (0.476) NA
 rs4986790 9 120475302 TLR4 A/G 2.01 0.285 (0.186) 1.277 (1.432) NA
2nd PC, female 
participants
 rs28470352 X 153753490 G6PD T/A 2.22 −0.046 (0.098) 0.983 (0.266) NA
 rs5986990 X 153761628 G6PD G/A 2.04 −0.056 (0.091) 0.893 (0.289) NA
 rs2515904 X 153762771 G6PD G/C 2.06 −0.005 (0.109) 2.484 (0.706) NA
 rs1050829 X 153763492 G6PD T/C 2.66 −0.084 (0.093) 1.011 (0.283) NA
 rs1050828 X 153764217 G6PD C/T 2.21 0.177 (0.156) 2.119 (0.571) NA
 rs762516 X 153764663 G6PD C/T 2.11 −0.018 (0.110) 2.434 (0.699) NA
Abbreviations: Chr, chromosome; NA, not applicable; PC, principal component; SE, standard error; SNP, single-nucleotide polymorphism. 
aEstimates based on log fAA/(fAB+fBB).
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“malaria-associated” polymorphisms showed any such variation 
and/or association. Of the 70 genes analyzed, only 6 (CD36, 
DDC, IL3, IL13, CTLA4, and PDLIM4) showed any direct asso-
ciation with malaria transmission measures. Interestingly, poly-
morphisms in all of these loci were significantly associated with 
parasite prevalence, but only 2 (CD36 and DDC) were associated 
with altitude and only 1 (CD36) with SCR. Although located in 
the same chromosome, these genes are not linked to each other. 
Three other loci (CR1, TNF, and TLR4) showed borderline asso-
ciations with the principal component 2 but not with any partic-
ular measure of malaria transmission.
Village-level prevalence of the CD36 polymorphism 
(rs3211938) was associated with all 3 transmission intensity 
measures and with the principal component representing puta-
tive long-term effects of malaria exposure. CD36 is a ubiqui-
tously expressed scavenger receptor and a major receptor for 
the Plasmodium falciparum erythrocyte membrane protein 1 
family of erythrocyte surface proteins, responsible for seques-
tration and rosetting of malaria-infected red blood cells [38]. 
Although an early study suggested an association between CD36 
mutations and susceptibility to severe malaria [39], this link has 
not been substantiated, and an extensive multiple-country anal-
ysis indicated that the high prevalence of the rs3211938 poly-
morphism in African populations is mostly likely maintained 
by factors other than malaria [40]. However, the consistent 
association of rs3211938 with 3 different measures of malaria 
transmission intensity suggests that CD36 may indeed contrib-
ute to protection against malaria, but perhaps through its role 
in macrophages as a nonopsonic mediator of phagocytosis or 
through its role in hemostasis and thrombosis, rather than as an 
endothelial receptor for infected erythrocytes.
Several linked polymorphisms in the DDC locus were associ-
ated with parasite prevalence and the principal component per-
taining to variation between intermediate and current malaria 
exposure. This result is agreement with 2 recent studies from 
Tanzania [28] and Gambia [41] that detected a possible role for 
DDC in severe malaria. Because these various polymorphisms 
are all in linkage disequilibrium with each other, the corre-
sponding genetic effect might reflect haplotypes protecting 
from malaria, as demonstrated for the G6PD locus in a study 
from Tanzania [33]. A detailed analysis of individual haplotype 
associations was beyond the scope of the current work.
Genetic variations in several immune-response genes (CR1, 
TNF, TLR4, IL3, IL13, and CTLA4), as well as in RAD50, 
SLC22A4, and PDLIM4, were found to be moderately associ-
ated with parasite prevalence and the alternative measure of 
current transmission intensity based on the second principal 
component. Because these polymorphisms were associated only 
with these measures of transmission intensity, one can ques-
tion their possible replication in future studies. In this regard, 
parasite rate can be affected by the study design used, time of 
sampling, seasonal effects on malaria transmission, and sensi-
tivity/specificity of the diagnostic test. Therefore, this measure 
should be considered less robust than altitude and SCR, which 
capture longer time scales of transmission intensity.
In summary, genetic associations concerning common red 
blood cell polymorphisms were confirmed using different mea-
sures of malaria transmission intensities. The remaining asso-
ciations would seem less robust and less likely to be replicated, 
because they are related to parasite rate and an alternative mea-
sure of current transmission intensity. The adopted approach 
therefore shows the advantage of finding genetic associations 
that are likely to persist over time.
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